Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.8349
+0.01491.82%
Post-market: 0.7800-0.0549-6.58%19:29 EDT
Volume:477.71K
Turnover:403.07K
Market Cap:27.71M
PE:-0.33
High:0.9000
Open:0.8231
Low:0.7862
Close:0.8200
Loading ...
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
Apr 19, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2023

Major Issues Report

8-K - Current report
Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 28, 2022

Major Issues Report

8-K - Current report
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2022

Major Issues Report

8-K - Current report